TNFA (tnfpharma.com) Quarterly Revenue Growth

Corporate emblem and logo of TNF Pharma (TNFA)

While the short-term value of TNF Pharmaceuticals (TNFA) depends on the outcomes of Phase 2/3 trials, long-term sustainability is based on unique patents and strict FDA control. A stable R&D core minimizes personnel risks. The magnitude of quarterly revenue growth helps identify market overheating by fixing the metric value at 0.00, which cautions investors against purchasing the asset at its peak valuation.

TNF Pharmaceuticals (TNFA) - Quarterly Revenue Increase from 07/25/2024 to 09/25/2025

Analytical breakdowns for TNF Pharma (TNFA)

- cash position and cash flow details:
Analysis of all company metrics:TNFA - TNF Pharma
Manufactured products of TNF Pharmaceuticals Inc.

This indicator measures operating income dynamics on a quarterly basis, allowing for an assessment of the business's scaling speed and its ability to generate liquidity to cover obligations. An analysis of quarterly revenue growth confirms the effective monetization of the unique immunological developments of TNF Pharmaceuticals (TNFA), where the company's pricing power directly converts into asset stability and investment attractiveness.

Competing companies

HLN - Revenue Growth QoQ|Quarterly Revenue Growth Rate kenvue.com|Verona Pharma (VRNA) - Revenue Growth QoQ|Quarterly Revenue Growth Rate Jyong Biotech Limited (MENS)|LGND (Ligand Pharmaceuticals Incorporated) - Quarterly Revenue Growth|Quarterly Revenue Growth Rate Amneal Pharmaceuticals Inc AMRX|Quarterly Revenue Growth PRGO|Sales Change QoQ ALVO|Quarterly Revenue Growth LQDA (Liquidia Technologies)|Quarterly Revenue Growth Galapagos GLPG|ANI Pharmaceuticals Inc - Quarterly Revenue Growth|MNKD (MannKind Corp.) - Sales Growth QoQ|AMPH: Quarterly Revenue Growth|PCRX (Pacira BioSciences) - Revenue Growth QoQ|Revenue Growth QoQ ARS Pharmaceuticals Inc|Quarterly Sales Growth Theravance Biopharma, Inc. (TBPH)|Quarterly Sales Growth AQST (Aquestive Pharma)|SCPH - Quarterly Revenue Growth Rate|Quarterly Revenue Growth TECX (Tectonic Therapeutic, Inc.)|TNXP - Quarterly Sales Growth|China SXT Pharmaceuticals, Inc. - Quarterly Revenue Growth|EPRX - Quarterly Revenue Growth|BHST: Quarterly Revenue Growth|Quarterly Revenue Growth Rate eXoZymes Inc (EXOZ)|ORMP (oramed.com) - Quarterly Revenue Growth|Sales Growth QoQ ENTX (Entera Bio)|Revenue Growth QoQ MindWalk (HYFT)|Quarterly Revenue Growth ABVC BioPharma, Inc. (ABVC)|Revenue Growth QoQ Cumberland Corp CPIX|QNTM - Quarterly Sales Growth|FGEN - Revenue Growth QoQ|TELO - Quarterly Revenue Growth|Rani Therapeutics Inc (RANI) - Revenue Growth QoQ|Sales Growth QoQ SNYR|Revenue Growth QoQ Rallybio Corp|Revenue Growth QoQ LEXX|Quarterly Revenue Growth PULM|PTHL: Revenue Dynamics QoQ|Quarterly Revenue Growth APM (Aptorum Group Ltd)|LYRA - Quarterly Sales Growth|Impact BioMedical Inc - Quarterly Revenue Growth|Quarterly Revenue Growth Rate cbdMD Inc.|PainReform Ltd. (PRFX) - Revenue Growth QoQ|Quarterly Revenue Growth Rate Altamira Therapeutics (CYTO)|Revenue Growth QoQ Lipella Pharmaceuticals, Inc.|OPTN: Quarterly Revenue Increase|Revenue Growth QoQ Pieris (PIRS)|Quarterly Revenue Growth Procaps Group Corp (PROC)|Quarterly Revenue Growth PTPI (petrospharma.com)|Quarterly Revenue Increase QLI|ACELYRIN - Quarterly Revenue Growth|Quarterly Revenue Increase TFFP (TFF Pharmaceuticals Inc.)